Back
Novo Nordisk AS Vs. Apogee Enterprises Industry Stock Comparison
Sell
27
NONOF
Novo Nordisk AS
Last Price:
114.04
Seasonality Move:
8.17%
Buy
80
APOG
Apogee Enterprises
Last Price:
83.90
Seasonality Move:
5.81%
Sell
27
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NONOF] share price is $114.04. The Score for NONOF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Apogee Enterprises (APOG)
is a Buy
Is Apogee Enterprises a Buy, Sell or Hold?
- The current Apogee Enterprises [APOG] share price is $83.93. The Score for APOG is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- APOG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $114.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
APOG Stock Price Chart
What is Apogee Enterprises's stock price today?
-
The Apogee Enterprises share price today is $83.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APOG is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.81 | Sell |
| Relative Strength Index (14 RSI): | 33.76 | Sell |
| Chaikin Money Flow: | 1570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.57 - 136.19) | Sell |
| Bollinger Bands (100): | (127.16 - 141.68) | Sell |
APOG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.45 | Buy |
| Relative Strength Index (14 RSI): | 80.6 | Buy |
| Chaikin Money Flow: | 521126 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.86 - 71.48) | Buy |
| Bollinger Bands (100): | (60.99 - 67.83) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 119.03 | Sell |
| 20-day SMA: | 126.6 | Sell |
| 50-day SMA: | 130.02 | Sell |
| 200-day SMA: | 127.01 | Sell |
| 8-day EMA: | 118.69 | Sell |
| 20-day EMA: | 124.33 | Sell |
| 50-day EMA: | 129.2 | Sell |
| 200-day EMA: | 124.31 | Sell |
APOG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.06 | Buy |
| 20-day SMA: | 67.97 | Buy |
| 50-day SMA: | 65.81 | Buy |
| 200-day SMA: | 60.61 | Buy |
| 8-day EMA: | 72.16 | Buy |
| 20-day EMA: | 69.1 | Buy |
| 50-day EMA: | 66.48 | Buy |
| 200-day EMA: | 60.64 | Buy |
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.
Apogee Enterprises Earnings Growth & APOG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.67 per share, and an increase next year of $0.18 per share.
Novo Nordisk AS Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apogee Enterprises Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||